Get the Stockscreener App
304.35
1.13%
3.40
After Hours:
301.91
-2.44
-0.80%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $304.35, with a volume of 1.13M.
It is up +1.13% in the last 24 hours and up +1.43% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
See More
Previous Close:
$300.95
Open:
$302.66
24h Volume:
1.13M
Relative Volume:
0.61
Market Cap:
$81.24B
Revenue:
$261.22B
Net Income/Loss:
$5.40B
P/E Ratio:
16.61
EPS:
18.32
Net Cash Flow:
$3.94B
1W Performance:
+2.52%
1M Performance:
+1.43%
6M Performance:
+1.51%
1Y Performance:
-12.16%
1-Day Range:
$302.42
$308.42
1-Week Range:
$297.50
$308.42
52-Week Range:
$256.89
$370.82
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
304.35 | 79.63B | 261.22B | 5.40B | 3.94B | 18.32 |
|
UNH
Unitedhealth Group Inc
|
307.42 | 279.39B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
71.30 | 89.00B | 386.46B | 4.49B | 4.78B | 3.58 |
|
ELV
Elevance Health Inc
|
316.55 | 69.65B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
299.51 | 34.54B | 123.11B | 1.58B | 2.44B | 13.03 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Cigna Insider Stock Sales: A Window into Executive Liquidity and Corporate Governance - AInvest
Cigna Group's Q2 2025 Earnings: What to Expect - MSN
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today - 富途牛牛
AI Trend Models Suggest Bounce for The Cigna GroupJuly 2025 Levels & Fast Exit Strategy with Risk Control - sundaytimes.kr
Could Easing Medicare Advantage Rules Reshape Cigna’s (CI) Competitive Edge in Healthcare Innovation? - simplywall.st
What’s the outlook for The Cigna Group’s sectorJuly 2025 PostEarnings & Weekly Momentum Picks - thegnnews.com
Is The Cigna Group a strong candidate for buy and holdIPO Watch & Daily Technical Forecast Reports - newsyoung.net
Cigna: Market Pessimism Creates Value Opportunity - Seeking Alpha
Cigna Group stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Cigna Group's Q2 2025 Earnings: Strategic Reinvention and the Road to Resilience - AInvest
Cigna Group shares rise 1.33% premarket after Baird raised its price target to $372. - AInvest
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI) - Yahoo Finance
Stock Analysis | The Cigna OutlookNavigating Volatility Amid Mixed Signals - AInvest
Cigna Group shares rise 1.83% after-hours as Wells Fargo raises price target to $340. - AInvest
Baird Adjusts Cigna Group Price Target to $372 From $364 - MarketScreener
Wells Fargo Adjusts Price Target on Cigna Group to $340 From $341, Maintains Equalweight Rating - MarketScreener
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS - Benzinga
Ballad And Cigna Reach In-Network Agreement - GreenevilleSun.com
Raising Our Uncertainty Ratings on Cigna and Elevance on Medical Utilization and Regulatory Concerns - Morningstar
Uncertainty Rising at Cigna Primarily on Risks to Its PBM Operations - Morningstar
Do Wall Street Analysts Like Cigna Group Stock? - Yahoo Finance
How Aetna, Cigna, UnitedHealth stacked up in Q2 earnings - Modern Healthcare
What makes The Cigna Group stock price move sharplyHigh Impact Investment Signals - thegnnews.com
Cigna's 226th-Ranked Trading Volume Contrasts With High-Liquidity Stocks' Outperformance in Volatile Markets - AInvest
Earnings Surge and Major Buybacks Could Be a Game Changer for Cigna Group (CI) - simplywall.st
iTournament: Empowering employees to drive innovation at The Cigna Group - The Cigna Group Newsroom
Integrated medical, dental, and behavioral health treatment can lead to better health outcomes - Cigna Healthcare Newsroom
Cigna (CI) Pullback a Buying Opportunity, Says TD Cowen with a Buy Rating - MSN
What Cigna Group (CI)'s Strong Q2 Earnings and Share Buyback Reveal About Shareholder Value - simplywall.st
A transformative journey across the Midwest: Suzan Brydon’s Community Ambassador Fellowship story - The Cigna Group Newsroom
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid - TradingView
We Think Cigna Group's (NYSE:CI) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Cigna’s Growth Story Comes With Margin Worries Attached - Finimize
J.P. Morgan Maintains Cigna Group(CI.US) With Buy Rating, Announces Target Price $428 - 富途牛牛
Cigna vs. UnitedHealth Group: Why Cigna Offers a More Attractive Value-Driven Investment in the Health Care Providers & Services Sector - AInvest
Cigna: Looks More Interesting Here Than UnitedHealth Group (NYSE:CI) - Seeking Alpha
Wall Street sours on health insurance - Modern Healthcare
Bert Nash cancels its contract with insurer Cigna; 121 patients could be affected - Lawrence Journal-World
Cigna (CI) Surges 2.2% on Strategic Expansion and Analyst Optimism: Is This the Start of a Bullish Rebound? - AInvest
Does Cigna Group's (CI) Margin Pressure Challenge Its Long-Term Growth Narrative? - simplywall.st
Cigna Expands Flexible Dental Payment Solution to 2.8 Million More Members, Driving Increases in Preventive Care and Critical Procedures - AInvest
Skipping the Dentist? Not Anymore: Cigna Expands Access to Flexible Dental Payments, Driving Meaningful Increases in Preventive Care and Critical Procedures - Nasdaq
Deutsche Bank Adjusts Cigna Group Price Target to $415 From $372, Maintains Buy Rating - MarketScreener
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes - MSN
Cigna's $660M Volume Falls 26.2% to 150th Market Rank as Shares Rise 1.66% on Strategic Shifts and Expanded Partnerships - AInvest
Elevated Medicare Advantage, ACA marketplace costs sting insurers in mixed Q2 - Fierce Healthcare
Guggenheim Maintains Cigna Group(CI.US) With Buy Rating, Cuts Target Price to $350 - 富途牛牛
Elite Investors see life in Cigna - Citywire
The Cigna Group Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
Is The Cigna Group a good long term investmentMaximize portfolio growth with strategic plans - Jammu Links News
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
2.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):